Literature DB >> 31580491

A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer.

Cheryl C Nocon1,2, Gaurav S Ajmani3, Mihir K Bhayani1,2.   

Abstract

BACKGROUND: Racial disparities in squamous cell carcinoma of the head and neck (HNSCC) negatively affect non-Hispanic black (NHB) patients. This study was aimed at understanding how treatment is prescribed and received across all HNSCC subsites.
METHODS: With the National Cancer Database, patients from 2004 to 2014 with surgically resectable HNSCCs, including tumors of the oral cavity (OC), oropharynx (OP), hypopharynx (HP), and larynx (LX), were studied. The treatment received was either upfront surgery or nonsurgical treatment. Treatment patterns were compared according to race and subsite, and how these differences changed over time was evaluated.
RESULTS: NHB patients were less likely than non-Hispanic white (NHW) patients to receive surgery across all subsites (relative risk [RR] for OC, 0.87; RR for OP, 0.75; RR for HP, 0.73; RR for LX, 0.87; all P values <.05). They were also more likely to refuse a recommended surgery (RR for OC, 1.50; RR for OP, 1.23; RR for HP, 1.23; RR for LX, 1.34), and this difference was significant except for HP. NHB patients were more likely to not be offered surgery across all subsites (RR for OC, 1.38; RR for OP, 1.07; RR for HP, 1.05; RR for LX, 1.03; all P values <.05). Rates of surgery increased and rates of not being offered surgery declined for both NHB and NHW patients from 2004 to 2014, but the absolute disparities persisted in 2014.
CONCLUSIONS: Across all HNSCC subsites, NHB patients were less likely than NHW patients to be recommended for and receive surgery and were more likely to refuse surgery. These differences have closed over time but persist. Enhanced shared decision making may improve these disparities.
© 2019 American Cancer Society.

Entities:  

Keywords:  head and neck neoplasms; health care disparities; race factors

Mesh:

Year:  2019        PMID: 31580491     DOI: 10.1002/cncr.32342

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Health Disparities: Impact of Health Disparities and Treatment Decision-Making Biases on Cancer Adverse Effects Among Black Cancer Survivors.

Authors:  Jacqueline B Vo; Arielle Gillman; Kelsey Mitchell; Timiya S Nolan
Journal:  Clin J Oncol Nurs       Date:  2021-10-01       Impact factor: 1.027

Review 2.  Acknowledging and Addressing Allostatic Load in Pregnancy Care.

Authors:  Kirsten A Riggan; Anna Gilbert; Megan A Allyse
Journal:  J Racial Ethn Health Disparities       Date:  2020-05-07

Review 3.  Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity.

Authors:  Manisha Salinas; Ashish Chintakuntlawar; Ivie Arasomwan; Ahmed Eltahir; Katharine A R Price
Journal:  Curr Oncol Rep       Date:  2022-04-14       Impact factor: 5.945

4.  Cardioprotective medication use in Black and white breast cancer survivors.

Authors:  Arnethea L Sutton; Ashley S Felix; Dipankar Bandyopadhyay; Reuben Retnam; William G Hundley; Vanessa B Sheppard
Journal:  Breast Cancer Res Treat       Date:  2021-04-02       Impact factor: 4.624

5.  Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment 18F-PET/CT.

Authors:  Zheran Liu; Yuan Cao; Wei Diao; Yue Cheng; Zhiyun Jia; Xingchen Peng
Journal:  Aging (Albany NY)       Date:  2020-07-16       Impact factor: 5.682

6.  HSD17B7 gene in self-renewal and oncogenicity of keratinocytes from Black versus White populations.

Authors:  Xiaoying Xu; Beatrice Tassone; Paola Ostano; Atul Katarkar; Tatiana Proust; Jean-Marc Joseph; Chiara Riganti; Giovanna Chiorino; Zoltan Kutalik; Karine Lefort; Gian Paolo Dotto
Journal:  EMBO Mol Med       Date:  2021-06-29       Impact factor: 12.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.